
U.S. Veterinary Orthopedic Implants Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The U.S. veterinary orthopedic implants market was estimated at USD 237.2 million in 2024. The market is expected to grow from USD 252.1 million in 2025 to USD 499.2 million in 2034, growing at a CAGR of 7.9% during the forecast period, according to the latest report published by Global Market Insights Inc. As the pet owners increasingly consider pets as family members, there is a growing willingness to invest in advanced veterinary care, including surgical procedures.

For instance, as per the American Pet Products Association (APPA), pet expenditure in the U.S. reached USD 151.9 billion in 2024 from USD 147 billion in 2023, and is expected to reach USD 157 billion by 2025. These increasing animal healthcare expenditures highlight a growing demand for veterinary care products and services. Thus, a high pet population in the region, coupled with high veterinary expenses, increases the demand for various pet care services, including surgeries, thereby driving the market growth.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 237.2 Million |
| Market Size in 2025 | USD 252.1 Million |
| Forecast Period 2025 - 2034 CAGR | 7.9% |
| Market Size in 2034 | USD 499.2 Million |
| Key Market Trends | |
| Drivers | Impact |
| Rising penetration of pet insurance | It improves the affordability of orthopedic procedures, encouraging more pet owners to opt for advanced surgical treatments. |
| Growing incidence of musculoskeletal disorders in animals | High incidence of musculoskeletal disorders has increased the demand for implants to treat fractures, arthritis, and ligament injuries in both pets and livestock. |
| Rising pet ownership and humanization | Rising pet ownership drives spending on veterinary care, especially orthopedic procedures, as pets are increasingly seen as family members. |
| Pitfalls & Challenges | Impact |
| High cost of orthopedic procedures and implants | Limits access for many pet owners, particularly those without insurance or in low-income regions. |
| Post-surgical complications and recovery time | Discourages some pet owners from opting for surgery, impacting overall adoption rates of implants. |
| Opportunities: | Impact |
| Emergence of biodegradable and resorbable implants | Emergence of biodegradable and resorbable implants will reduce the need for secondary surgeries, improving patient recovery and increasing acceptance among veterinarians and pet owners. |
| Expansion of veterinary specialty hospitals and referral centers | Improving access to advanced orthopedic care will boost surgical procedure volume and implant demand. |
| Market Leaders (2024) | |
| Market Leaders |
~32.2% market share. |
| Top Players |
Collective market share in 2024 is ~54.5% |
| Competitive Edge |
|
| Regional Insights | |
| Largest Market | South Atlantic |
| Fastest Growing Market | West South Central |
| Emerging Zones | North East, Pacific Central, East South Central, East North Central |
| Future outlook |
|
Veterinary orthopedic implants are medical devices used for correcting fractures, stabilizing joints, and assisting bone healing in animals. These implants consist of bone plates, screws, pins, wires, and prosthetic joints designed to resist the biomechanical stresses of various species. Key market players such as DePuy Synthes (Johnson & Johnson), B. Braun, Movora (Vimian Group AB), Arthrex Vet Systems, and Veterinary Instrumentation support the overall market growth. They shape the market through innovation in implant materials and design, R&D innovation, and new product launches. Furthermore, their strong distribution network enhances the availability and accessibility of high-quality products across the country.
In 2021, the U.S. veterinary orthopedic implants market was valued at USD 200.8 million and witnessed growth to reach USD 211.4 million and USD 223.5 million in 2022 and 2023, respectively. During this period, the market witnessed increasing use of advanced fixation devices such as locking plates, intramedullary nails, and patient-specific 3D-printed implants. This shift was driven by the growing demand for higher success rates in fracture repair, faster recovery, and the ability to treat complex cases in dogs, cats, and equines.
The COVID-19 pandemic also had a notable impact on pet ownership trends in the U.S. According to APPA, in 2010, about 62% of households owned a pet, including 46 million dog-owning households and 39 million cat-owning households. By 2024, these numbers had increased to 58 million for dogs and 40 million for cats. This rise translates into increased demand for veterinary care, including specialized treatments like orthopedic surgeries.
Veterinary orthopedic implants, typically manufactured from metals such as titanium or stainless steel, play a vital role in restoring function to fractured bones or replacing damaged joints, bones, or cartilage. These implants are essential in managing fractures, joint disorders, and other musculoskeletal conditions in animals.

Based on the product, the U.S. veterinary orthopedic implants market is divided into implants and instruments. The implants segment is further sub-segmented into plates, joint implants, bone screws and anchors, pins and wires, and other implants. The implants segment dominated the market in 2024 with USD 167.8 million and is expected to reach USD 358.4 million by 2034.

Based on animal type, the U.S. veterinary orthopedic implants market is categorized into small and medium animals and large animals. The small and medium animal’s segment is further categorized into dogs, cats, and other small and medium animals. The small and medium animals segment dominated the market in 2024 with a market share of 72.6%.
On the other hand, the large animal’s segment is poised to grow at a 7.1% CAGR over the analysis period. This growth is driven by the economic importance of large animals like horses and cattle, encouraging producers and breeders to invest in advanced orthopedic care to maintain animal health and productivity.
Based on the application, the U.S. veterinary orthopedic implants market is categorized into Tibial Plateau Leveling Osteotomy (TPLO), Tibial Tuberosity Advancement (TTA), joint replacement, trauma, and other applications. The joint replacement segment is further sub-categorized into hip replacement, knee replacement, elbow replacement, and ankle replacement. The joint replacement segment held the highest market share of 28.3% in 2024.
Based on the end use, the U.S. veterinary orthopedic implants market is classified into veterinary hospitals and clinics and other end users. The veterinary hospitals and clinics segment accounted for revenue of USD 203.4 million in 2024 and is anticipated to grow at a CAGR of 8.1% over the analysis period.

South Atlantic Veterinary Orthopedic Implants Market
The South Atlantic zone dominated the U.S. veterinary orthopedic implants market with a market share of 23.6% in 2024.
The Florida veterinary orthopedic implants market was valued at USD 9 million and USD 9.4 million in 2021 and 2022, respectively. The market size reached USD 10.4 million in 2024, growing from USD 9.8 million in 2023.
The Georgia veterinary orthopedic implants market is predicted to witness considerable growth over the analysis period.
The veterinary orthopedic implants market in the Pacific Central zone of the U.S. was valued at USD 39.9 million in 2024 and is anticipated to witness significant growth over the analysis period.
The veterinary orthopedic implants market is experiencing significant expansion, driven by the growing incidence of orthopedic disorders in both companion and livestock animals, rising pet ownership, and increasing demand for advanced surgical interventions. This market encompasses leading global healthcare companies, medical device manufacturers, and veterinary-focused firms delivering innovative orthopedic solutions.
The top 5 players, including DePuy Synthes (Johnson & Johnson), B. Braun, Movora (Vimian Group AB), Arthrex Vet Systems, and Veterinary Instrumentation, collectively account for an estimated 52 – 57% of the total market share. These players maintain their competitive edge through a combination of strong brand recognition, broad product portfolios, technological innovation, and extensive distribution networks across the U.S.
Further, technological advancements such as 3D printing, customized implant design, and minimally invasive surgical techniques are revolutionizing veterinary orthopedics. Additionally, growing veterinary infrastructure, strategic collaborations with veterinary hospitals, and investments in research and development are driving market expansion.
Few of the prominent players operating in the U.S. veterinary orthopedic implants industry include:
DePuy Synthes, a subsidiary of Johnson & Johnson, is a leading player in the veterinary orthopedic implants market, holding approximately 32.2% market share. The company provides a comprehensive portfolio of implants and instruments designed to treat fractures, joint disorders, and musculoskeletal conditions in companion animals. Leveraging advanced technologies such as 3D printing, bioabsorbable materials, and minimally invasive surgical systems, DePuy Synthes enhances implant performance and improves surgical outcomes.
Movora, a subsidiary of Vimian Group AB, operates exclusively in the veterinary orthopedic implants market, offering a dedicated portfolio of implants and surgical instruments. The company emphasizes innovation in orthopedic solutions, including advanced joint replacement systems, fixation devices, and plates specifically designed for companion animals. By engaging in strategic collaborations with veterinary clinics, launching educational initiatives, and partnering with veterinary surgeons, Movora continues to strengthen its market presence.
B. Braun maintains a strong foothold in the U.S. veterinary orthopedic implants market with its broad range of high-quality plates, screws, and surgical instruments for small and medium animals. The company’s precision-engineered implants and comprehensive surgical kits ensure reliable outcomes, driving surgeon preference. Its consistent emphasis on innovation, product safety, and quality has enabled B. Braun to retain a competitive edge within the expanding veterinary orthopedic segment.
Market, By Product
Market, By Animal Type
Market, By Application
Market, By End Use
The above information is provided for the following zones and states:
Key players include AmerisourceBergen Corporation (Cencora), Arthrex Vet Systems, B. Braun, BlueSAO, DePuy Synthes (Johnson & Johnson), Fusion Implants, GerVetUSA, GPC Medical, Integra LifeSciences, Movora (Vimian Group), Narang Medical Limited, and Ortho Max.
Key trends include advancements in implant materials like titanium alloys and bioresorbable polymers, the rise of minimally invasive surgical techniques, and the increasing availability of implants designed for such procedures.
The South Atlantic zone led the market with a 23.6% share in 2024, driven by a high concentration of veterinary practices and pet ownership in the region.
The joint replacement segment held the highest market share of 28.3% in 2024.
The implants segment is expected to reach USD 358.4 million by 2034.
The market size was USD 237.2 million in 2024, with a CAGR of 7.9% expected through 2034, driven by advancements in implant materials and the increasing adoption of minimally invasive surgical techniques.
The market is expected to reach USD 252.1 million in 2025.
The implants segment generated USD 167.8 million in 2024, dominating the market.
The market is expected to reach USD 499.2 million by 2034, fueled by innovations in implant technology and growing investments in advanced veterinary care.


